Did loonie pay to much for a compound no one wanted. A big pharm gave up on a drug and sold the rights to company B for $2 and milestones in the future of $18M. Now loonie comes along and pays $6 M upfront and 10% of the company and something like $115M in milestones for that same drug. I'd be carefull with TSRO.
Remember when a deal was in the works and institutions were driving down share. I email Lobbies something was up and he need to announce it. Next day they MGI Pharmas posted announcement exploring options. I too think Astex has same potential. Even more than MGI.